CARsgen Therapeutics Holdings Limited (2171.HK) HKSE

Currency In HKD

AD

Valuation

Market Cap7.36B
Enterprise Value6.3B
P/E Ratio-67.23
PEG Ratio-0.66
Price/Sales Ratio45
Price/Book Ratio5.45
Enterprise/Revenue35.29
Enterprise/EBITDA-22.22

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.65
Operating Margin-0.72
AD

Management Effectiveness

Return On Assets-0.06
Return On Equity-0.09

Income Statement

Revenue125.66M
Revenue/Share0.25
Gross Profit79.95M
EBITDA-203.91M
Net Income-97.86M
Diluted EPS-0.18

Balance Sheet

Total Cash1.4B
Total Cash/Share2.54
Total Debt71.98M
Total Debt/Equity0.07
Current Ratio7.07
Book Value Per Share1.98

Price History

52-Week Change-38.44
52-Week High28.6
52-Week Low10.87
Moving Average 50 Days14.35
Moving Average 200 Days16.26

Statistics

Average Volume4.24M
Shares Outstanding569.83M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD